Recherche
-
Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes
(Journal of Neurology. vol. 268, n° 3, pp. 879-890, 2021-03)Article de revue -
POMC neuronal heterogeneity in energy balance and beyond: an integrated view
(Nature Metabolism. vol. 3, n° 3, pp. 299-308, 2021-03)Article de revueLibre accès -
Epidemics and outbreaks of peripheral nervous system disorders: II. Toxic and nutritional causes
(Journal of Neurology. vol. 268, n° 3, pp. 892-902, 2021-03)Article de revue -
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis
(Revue Neurologique. vol. 177, n° 1-2, pp. 73-79, 2021-01)Article de revue -
(Re)contextualizing the Trauma to Prevent or Treat PTSD-Related Hypermnesia
(Chronic Stress. vol. 5, 2021-05-26)Article de revueLibre accès -
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
(Neurobiology of Disease. vol. 160, pp. 105533, 2021-12-01)Article de revueLibre accès -
CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
(Diabetes. vol. 70, n° 2, pp. 415-422, 2021-02)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Olfaction and anosmia: From ancient times to COVID-19
(Journal of the Neurological Sciences. vol. 425, 2021-06-15)Article de revueLibre accès -
Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
(Multiple Sclerosis and Related Disorders. vol. 48, 2021-02)Article de revueLibre accès